Anteris Competitors

Pink Sheets . USA . 
Stock . Anteris Technologies
AMEUF Stock  USD 6.50  0.43  7.08%   
Anteris Technologies competes with Cellink AB, Bone Biologics, BICO Group, Brain Scientific, and Aurora Spine; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Devices industry. Analyzing Anteris Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Anteris Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Anteris Technologies Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Anteris Technologies competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anteris Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.086.5011.92
Details
Intrinsic
Valuation
LowRealHigh
0.425.8411.26
Details
Naive
Forecast
LowNextHigh
1.877.2812.70
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.646.276.90
Details

Anteris Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Anteris Technologies and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Anteris and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Anteris Technologies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
BBLGW
+ 0.72
CLLKF
BCCOY
+ 0.7
BBLGW
TNON
+ 0.62
CLLKF
BBLGW
+ 0.54
AIMDW
TNON
+ 0.54
BBLGW
CLLKF
+ 0.53
AIMDW
  
High negative correlations   
ASAPF
- 0.94
BBLGW
ASAPF
- 0.78
CLLKF
ASAPF
- 0.68
BCCOY
TNON
- 0.59
ASAPF
ASAPF
- 0.59
AIMDW
TNON
- 0.0
BRSF

Risk-Adjusted Indicators

There is a big difference between Anteris Pink Sheet performing well and Anteris Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Anteris Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Anteris Technologies Competitive Analysis

The better you understand Anteris Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Anteris Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Anteris Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMEUF AIMDW ARMM CLLKF BBLGW BCCOY BRSF ASAPF TNON
 7.08 
 6.50 
Anteris
 52.73 
 0.03 
Ainos
 0.00 
 0.0009 
Armm
 9.34 
 3.01 
Cellink
 2.42 
 27.80 
Bone
 0.00 
 0.88 
BICO
 0.00 
 0.75 
Brain
 3.23 
 0.30 
Aurora
 2.14 
 2.29 
Tenon
Market Volatility
(90 Days Market Risk)
Relatively risky
Out of control
Very steady
Risky
Moderately volatile
Extremely Dangerous
Very steady
Out of control
Abnormally volatile
Market Performance
(90 Days Performance)
Very Weak
Solid
Very Weak
Very Weak
Insignificant
Very Weak
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Above Average
Low
High
High
Quite High
Low
Below Average
Very High
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Not Rated
Strong Sell
Hold
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
4.31
0.53
N/A
2.35
N/A
2.35
0.59
2.43
7.54
Net Asset
29.48 M
31.84 M
N/A
9.75 B
3.74 M
9.75 B
13.38 M
10.56 M
6.34 M
Profit Margin
N/A
N/A
N/A
0.0176
N/A
0.0176
N/A
-0.11
N/A
EBITDA
(20.21 M)
(8.77 M)
N/A
37.7 M
479.57 K
37.7 M
(8.32 M)
(1.9 M)
(15.53 M)
Operating Margin
-5.05
-359.85
N/A
N/A
N/A
N/A
-28.77
-0.1
-4.3
Current Valuation
196.49 M
N/A
N/A
973.88 M
N/A
766.24 M
12.28 M
25.13 M
2.42 M
Price To Book
10.09
N/A
N/A
1.23
N/A
0.63
N/A
4.22
1.65
Retained Earnings
(69 M)
(37.89 M)
N/A
N/A
(80.91 M)
N/A
N/A
N/A
(55.07 M)
Current Asset
17 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.62
1.41
N/A
2.1
0.74
2.1
-0.88
0.53
2.16
Number Of Employees
31
46
2
1.18 K
2
1.18 K
28
4
21
Shares Outstanding
13.9 M
N/A
N/A
69.07 M
N/A
282.3 M
105.4 M
66.73 M
3.14 M
Cash Flow From Operations
(18.81 M)
(4.69 M)
N/A
(409.2 M)
(9.56 M)
(409.2 M)
(5.87 M)
(2.13 M)
(12.18 M)
Total Debt
4.07 M
5.96 M
N/A
1.35 B
831.4 K
1.35 B
9.97 M
2.27 M
1.86 M
Return On Equity
-2.55
-0.71
N/A
0.0068
-1.19
0.0068
-45.97
-0.27
-15.99
Z Score
29.0
N/A
N/A
N/A
N/A
N/A
18.6
5.4
N/A
Return On Asset
-0.84
-0.28
N/A
-0.025
-0.57
-0.025
-1.17
-0.0851
-1.1
Book Value Per Share
2.26
1.31
N/A
N/A
5.44
N/A
0.068
0.075
2.39
Number Of Shares Shorted
N/A
1.32 K
N/A
N/A
273
N/A
N/A
N/A
135.41 K
Current Liabilities
4 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
29.48 M
31.84 M
N/A
9.75 B
3.74 M
9.75 B
13.38 M
10.56 M
6.34 M
Debt To Equity
0.13
3.87
N/A
0.26
N/A
0.26
0.18
0.58
0.067
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.11
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
8.0
Shares Owned By Institutions
28.34
N/A
N/A
26.8
N/A
N/A
18.54
N/A
1.8
Market Capitalization
218.95 M
N/A
N/A
657.9 M
N/A
654.31 M
316.21 M
21.68 M
7.34 M
Price To Earning
-3.2
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
30.51
N/A
N/A
4.61
N/A
2.37
26.56
1.7
2.18
Net Income
(22.91 M)
(13.77 M)
N/A
(227.6 M)
(8.95 M)
(227.6 M)
(9.1 M)
(2.36 M)
(15.58 M)
Earnings Per Share
-2.15
N/A
N/A
0.06
-0.14
0.01
-0.29
-0.038
287.92
Shares Owned By Insiders
13.27
N/A
N/A
38.5
N/A
N/A
23.83
17.89
1.7
Revenue
7.79 M
122.11 K
N/A
1.26 B
N/A
1.26 B
265.75 K
10.54 M
2.93 M
Working Capital
13 M
1.14 M
N/A
N/A
2.91 M
N/A
N/A
N/A
6.82 M
Cash And Equivalents
33.1 M
1.87 M
N/A
N/A
4.44 K
N/A
3.54 M
758.98 K
16.02 M
Cash Per Share
2.39
0.19
N/A
N/A
N/A
N/A
0.03
0.01
1.42
Gross Profit
6.15 M
N/A
N/A
1.03 B
N/A
1.03 B
83.23 K
4.83 M
(641 K)
Day Typical Price
6.5
0.0357
9.0E-4
3.01
27.8
0.88
0.75
0.3
2.3
Accumulation Distribution
N/A
0.53
N/A
N/A
N/A
N/A
N/A
1633.33
1592.78
Market Facilitation Index
N/A
0.029
N/A
N/A
N/A
N/A
N/A
N/A
0.0
Daily Balance Of Power
9.2 T
(1.00)
0.0
(9,223,372,036,855)
(9,223,372,036,855)
0.0
0.0
(1.00)
(0.83)
Period Momentum Indicator
0.43
(0.03)
N/A
(0.31)
(0.69)
N/A
N/A
(0.01)
(0.05)
Rate Of Daily Change
1.07
0.47
1.0
0.91
0.98
1.0
1.0
0.97
0.98
Day Median Price
6.5
0.0405
9.0E-4
3.01
27.8
0.88
0.75
0.3
2.3
Price Action Indicator
0.21
(0.03)
N/A
(0.16)
(0.34)
N/A
N/A
N/A
(0.04)
Relative Strength Index
30.34
44.14
N/A
3.0
33.53
16.71
N/A
64.3
40.77
Coefficient Of Variation
(1,051)
777.21
N/A
(1,170)
1860.38
(1,751)
N/A
827.27
(35,858)
Mean Deviation
3.26
22.95
N/A
1.58
5.38
0.7834
N/A
3.92
7.95
Jensen Alpha
(0.53)
6.51
N/A
(0.54)
1.12
(0.21)
N/A
0.6858
(0.11)
Total Risk Alpha
(1.42)
(1.58)
N/A
(1.25)
(2.70)
(0.79)
N/A
(0.28)
(2.44)
Sortino Ratio
N/A
0.1724
N/A
N/A
N/A
N/A
N/A
0.0811
N/A
Downside Variance
N/A
893.43
N/A
N/A
N/A
N/A
N/A
48.98
N/A
Standard Deviation
5.39
41.12
N/A
4.91
23.73
3.46
N/A
5.83
14.34
Kurtosis
4.68
12.96
N/A
35.08
45.4
50.42
N/A
2.24
10.58
Potential Upside
7.73
76.79
N/A
N/A
N/A
N/A
N/A
11.11
34.08
Treynor Ratio
(13.87)
(0.55)
N/A
(0.50)
1.15
(7.75)
N/A
9.39
(0.10)
Maximum Drawdown
34.22
283.46
N/A
47.52
183.08
35.57
N/A
36.13
90.53
Variance
29.05
1690.98
N/A
24.09
562.96
11.98
N/A
34.04
205.52
Market Risk Adjusted Performance
(13.86)
(0.54)
N/A
(0.49)
1.16
(7.74)
N/A
9.4
(0.09)
Risk Adjusted Performance
(0.06)
0.1082
N/A
(0.06)
0.0508
(0.04)
N/A
0.1011
0.0073
Skewness
1.17
2.95
N/A
(4.75)
5.3
(6.24)
N/A
0.6819
2.83
Semi Deviation
N/A
19.16
N/A
N/A
N/A
N/A
N/A
3.86
N/A
Information Ratio
(0.12)
0.1253
N/A
(0.11)
0.048
(0.1)
N/A
0.0973
(0.01)
Value At Risk
(7.85)
(41.86)
N/A
(2.16)
(1.43)
N/A
N/A
(9.09)
(16.00)
Expected Short fall
N/A
(40.64)
N/A
N/A
N/A
N/A
N/A
(7.90)
N/A
Downside Deviation
N/A
29.89
N/A
N/A
N/A
N/A
N/A
7.0
N/A
Semi Variance
N/A
367.16
N/A
N/A
N/A
N/A
N/A
14.91
N/A

Anteris Technologies Competition Performance Charts

Five steps to successful analysis of Anteris Technologies Competition

Anteris Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Anteris Technologies in relation to its competition. Anteris Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Anteris Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Anteris Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Anteris Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Anteris Technologies position

In addition to having Anteris Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Thematic Idea Now

Communication
Communication Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Anteris Pink Sheet

Anteris Technologies financial ratios help investors to determine whether Anteris Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anteris with respect to the benefits of owning Anteris Technologies security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY